. Author manuscript; available in PMC: 2021 Dec 13.

Published in final edited form as: Vet Comp Oncol. 2016 May 4;15(3):996–1013. doi: 10.1111/vco.12239

Table 4.

Histological and immunohistochemical characterization of the cMM included in the study

	Threshold	Overall population	Group A	Group B

Ki67	<19.5	4/37^a (10.81)^b	1/20^a (5.00)^b	3/17^a (17.65)^b
	≥19.5	33/37 (89.19)	19/20 (95.00)	14/17 (82.35)
Mitotic index (MI)	<4/10 hpf	1/38^a (2.63)^b	0/20^a (0.00)^b	1/18^a (5.56)^b
	≥4/10 hpf	37/38 (97.37)	20/20 (100.00)	17/18 (94.44)
Nuclear atypia	<30%	12/38 (31.58)	5/20 (25.00)	7/18 (38.89)
	≥30%	26/38 (68.42)	15/20 (75.00)	11/18 (61.11)

Number of patients for which the data were available.

% in brackets.